STADA Philippines Strengthens OTC Portfolio in the country
Last February 7, 2020, the STADA Group formally introduced its expanding its portfolio in the Asia-Pacific region after announcing a number of acquisitions and partnerships in Europe. Strengthening their stride as the the global manufacturer of high-quality generic drugs and consumer healthcare products, they finally launched the acquisition of the FERN portfolio in the Philippines.
